{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:59:07Z","timestamp":1779263947103,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":2082,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Comprehensive Cancer Network (NCCN) from general research support provided by Celgene, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1093\/annonc\/mdt579","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T01:51:26Z","timestamp":1391565086000},"page":"689-694","source":"Crossref","is-referenced-by-count":25,"title":["Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III\u2013IVB head and neck squamous cell carcinoma (HNSCC)"],"prefix":"10.1016","volume":"25","author":[{"given":"M.G.","family":"Fury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wolden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Smith-Marrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.Y.","family":"Gelblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Katabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.G.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt579_bb0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1093\/annonc\/mdt579_bb0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival from a phase 3 randomized trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0020","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1056\/NEJMe058306","article-title":"Cetuximab and radiotherapy for head and neck cancer","volume":"354","author":"Posner","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1093\/annonc\/mdt579_bb0025","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijrobp.2010.07.008","article-title":"Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head and neck cancer","volume":"81","author":"Koutcher","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdt579_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1200\/JCO.2012.46.9049","article-title":"Should cetuximab replace cisplatin for definitive chemoradiotherapy for locally advanced head and neck cancer","volume":"31","author":"Riaz","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jso.21438","article-title":"Induction chemotherapy in the management of head and neck cancer","volume":"101","author":"Fury","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0040","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2270::AID-CNCR24>3.0.CO;2-Q","article-title":"Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group Trial (PA390)","volume":"82","author":"Forastiere","year":"1998","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt579_bb0045","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","article-title":"Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer","volume":"23","author":"Hitt","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0050","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ijrobp.2011.02.062","article-title":"Phase II study of evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck","volume":"82","author":"Suntharalingam","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdt579_bb0055","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0060","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/1097-0142(20011115)92:10<2592::AID-CNCR1612>3.0.CO;2-4","article-title":"Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007)","volume":"92","author":"Damascelli","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt579_bb0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.1998.16.2.735","article-title":"Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck","volume":"16","author":"Brockstein","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1200\/JCO.2001.19.2.535","article-title":"Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer","volume":"19","author":"Rischlin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2006.09.056","article-title":"Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer","volume":"67","author":"Cohen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdt579_bb0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/07357900701357993","article-title":"A phase I trial of docetaxel-based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer","volume":"25","author":"Seiwert","year":"2007","journal-title":"Cancer Invest"},{"key":"10.1093\/annonc\/mdt579_bb0085","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.27986","article-title":"A phase I study of everolimus + docetaxel + cisplatin as induction chemotherapy for patients with locally and\/or regionally advanced head and neck cancer","volume":"119","author":"Fury","year":"2013","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt579_bb0090","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/1097-0142(19900801)66:3<564::AID-CNCR2820660326>3.0.CO;2-D","article-title":"A performance status scale for head and neck cancer patients","volume":"66","author":"List","year":"1990","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt579_bb0095","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1200\/JCO.2004.12.012","article-title":"Preliminary results of radiation therapy oncology group 97\u201303: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinoma of the head and neck","volume":"22","author":"Garden","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1634\/theoncologist.2011-0396","article-title":"Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy","volume":"17","author":"Vlacich","year":"2010","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdt579_bb0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt579_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/905091","article-title":"Nanoparticle albumin bound paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?","author":"Cucinotto","year":"2013","journal-title":"J Drug Deliv"},{"key":"10.1093\/annonc\/mdt579_bb0115","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1200\/jco.2011.29.15_suppl.5500","article-title":"A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas","volume":"29S","author":"Ang","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0120","first-page":"A29","article-title":"Phase II randomized trial of postoperative chemoradiation plus cetuximab for high-risk squamous cell carcinoma of the head and neck (RTOG 0234)","volume":"S14","author":"Kies","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdt579_bb0125","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/annonc\/mdr367","article-title":"Phase II study of combination cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck","volume":"23","author":"Hitt","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0130","article-title":"Outcome of patients treated with palliative weekly paclitaxel plus cetuximab in recurrent head and neck cancer after failure of platinum-based therapy","author":"Sosa","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1093\/annonc\/mdt579_bb0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.oraloncology.2012.09.003","article-title":"Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent\/metastatic head and neck cancer patients","volume":"49","author":"Jimenez","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0140","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.2011.39.5848","article-title":"Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small cell lung cancer: final results of a phase III trial","volume":"30","author":"Socinski","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt579_bb0145","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/cncr.27741","article-title":"A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck","volume":"119","author":"Adkins","year":"2013","journal-title":"Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419342711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419342711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/25\/3\/689\/16699060\/mdt579.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:34:16Z","timestamp":1624520056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419342711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0923753419342711"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt579","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}